J&J’s PROTEUS Data Doesn’t Just Beat the Standard of Care — It Buries It
J&J's Phase 3 PROTEUS trial shows apalutamide before and after surgery cuts metastasis or death risk in high-risk prostate...
apalutamide
J&J's Phase 3 PROTEUS trial shows apalutamide before and after surgery cuts metastasis or death risk in high-risk prostate...